New Key Statistics Module, Z-Score and F-Score
SZSE:301096 Key Ratios
Market Cap ¥ M | 4,597.42 |
Enterprise Value ¥ M | 4,573.44 |
P/E(ttm) | 15.69 |
PE Ratio without NRI | 14.17 |
Forward PE Ratio | 10.73 |
Price/Book | 1.62 |
Price/Sales | 4.03 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.10 |
Revenue (TTM) ¥ M | 1,118.00 |
EPS (TTM) ¥ | 2.65 |
Beneish M-Score | -1.56 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 53.60 |
y-y EBITDA Growth Rate % | 33.50 |
EV-to-EBIT | 14.86 |
EV-to-EBITDA | 14.86 |
PEG | 0.26 |
Shares Outstanding M | 108.92 |
Net Margin (%) | 25.63 |
Operating Margin % | 29.05 |
Pre-tax Margin (%) | 27.00 |
Quick Ratio | 1.68 |
Current Ratio | 1.84 |
ROA % (ttm) | 7.88 |
ROE % (ttm) | 10.72 |
ROIC % (ttm) | 12.18 |
Dividend Yield % | 0.71 |
Altman Z-Score | 3.46 |
SZSE:301096 Number of Guru Trades
SZSE:301096 Volume of Guru Trades
Gurus Latest Trades with SZSE:301096
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301096 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Insider Transactions
No Available Data